Replies to post #134137 on NorthWest Biotherapeutics Inc (NWBO)

[Evaluate]

Smokey, you wrote:

Quote:
"NWBO has decided to let the trial continue in order to have a clear insight into the survival tail. In this trial of 331 patients, the median time of enrollment was May of 2014 and the last patient was enrolled in November of 2014.
This means that even the last person enrolled will have three year survival data when the trial is stopped and the data analyzed and most will have far more." ... SOS

I believe the last patient was enrolled in November, 2015

This is how it reads now:

NWBO has decided to let the trial continue in order to have a clear insight into the survival tail. In this trial of 331 patients, the median time of enrollment was May of 2014 and the last patient was enrolled in November of 2015.
This means that even the last person enrolled will have two plus year survival data when the trial is stopped and the data analyzed and the overwhelming majority will three years or more.